These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25414075)

  • 1. Comment on: "Adverse drug reaction reporting by patients: an overview of fifty countries".
    Ahmad SR
    Drug Saf; 2015 Jan; 38(1):109-10. PubMed ID: 25414075
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' reply to Ahmad SR: "Adverse drug reaction reporting by patients: an overview of fifty countries".
    Margraff F; Bertram D
    Drug Saf; 2015 Jan; 38(1):111. PubMed ID: 25414076
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse drug reaction reporting by patients: an overview of fifty countries.
    Margraff F; Bertram D
    Drug Saf; 2014 Jun; 37(6):409-19. PubMed ID: 24748428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse reactions: know the risks.
    Shepherd M
    Nurs Times; 2011 Apr 5-11; 107(13):20. PubMed ID: 21678719
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical methods for the analysis of adverse event data.
    Kieser M
    Pharm Stat; 2016 Jul; 15(4):290-1. PubMed ID: 27324410
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adverse drug reactions reporting is helping "non substituable" prescription!].
    Jacquot J; Bagheri H; Montastruc JL
    Therapie; 2014; 69(3):259-61. PubMed ID: 24927508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Is the Plural of a 'Yellow' Anecdote?
    Evans SJ
    Drug Saf; 2016 Jan; 39(1):1-3. PubMed ID: 26597283
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug makers' adverse event reports are often incomplete, US report finds.
    McCarthy M
    BMJ; 2015 Feb; 350():h651. PubMed ID: 25652561
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety surveillance of longitudinal databases: further methodological considerations.
    Schuemie MJ
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):670-2; author reply 673-5. PubMed ID: 22678687
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety surveillance of longitudinal databases: methodological considerations.
    Norén GN; Hopstadius J; Bate A; Edwards IR
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):714-7. PubMed ID: 21638520
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: harmonization in pharmacoepidemiological studies: (twi)light at the end of the tunnel?
    Mangoni AA
    Curr Clin Pharmacol; 2014 May; 9(2):91-2. PubMed ID: 24702185
    [No Abstract]   [Full Text] [Related]  

  • 12. Reporting suspected adverse reactions.
    Diesel G; Anderson N; Ursich E
    Vet Rec; 2019 May; 184(20):623. PubMed ID: 31097563
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of Live Attenuated Influenza Vaccine in Children With Egg Allergy and Asthma.
    Kelso JM
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):81-2. PubMed ID: 26407364
    [No Abstract]   [Full Text] [Related]  

  • 14. What can data mining teach us about triptan safety that we don't already know?
    Loder E; Burch R
    Cephalalgia; 2014 Jan; 34(1):3-4. PubMed ID: 23918835
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative signal detection for vaccines.
    Hauben M; Madigan D; Patadia V; Sakaguchi M; van Puijenbroek E
    Hum Vaccin; 2010 Aug; 6(8):681. PubMed ID: 20495343
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of online reporting systems and their compatibility check with respective adverse drug reaction reporting forms.
    Maharshi V; Nagar P
    Indian J Pharmacol; 2017; 49(5):374-382. PubMed ID: 29515278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reporting bias in the analysis of spontaneous reporting data.
    Ghosh P; Dewanji A
    Pharm Stat; 2015; 14(1):20-5. PubMed ID: 25376637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.
    Matos C; Härmark L; van Hunsel F
    Drug Saf; 2016 Nov; 39(11):1105-1116. PubMed ID: 27581398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual impairment owing to adverse drug reaction: incidence and routine monitoring in the United kingdom.
    Cumberland PM; Russell-Eggitt I; Rahi JS
    Ophthalmology; 2014 May; 121(5):1152-4. PubMed ID: 24612978
    [No Abstract]   [Full Text] [Related]  

  • 20. [Knowledge creation about adverse drug reactions in the paediatric population].
    Aagaard L
    Ugeskr Laeger; 2013 Feb; 175(6):342-5. PubMed ID: 23402239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.